Cargando…

Multivalent vaccines against new SARS-CoV-2 hybrid variants

Detalles Bibliográficos
Autores principales: Ghazvini, Kiarash, Keikha, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212962/
https://www.ncbi.nlm.nih.gov/pubmed/35757082
http://dx.doi.org/10.1016/j.vacun.2022.06.002
_version_ 1784730731527798784
author Ghazvini, Kiarash
Keikha, Masoud
author_facet Ghazvini, Kiarash
Keikha, Masoud
author_sort Ghazvini, Kiarash
collection PubMed
description
format Online
Article
Text
id pubmed-9212962
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-92129622022-06-22 Multivalent vaccines against new SARS-CoV-2 hybrid variants Ghazvini, Kiarash Keikha, Masoud Vacunas Letter to the Editor Elsevier España, S.L.U. 2023 2022-06-17 /pmc/articles/PMC9212962/ /pubmed/35757082 http://dx.doi.org/10.1016/j.vacun.2022.06.002 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Ghazvini, Kiarash
Keikha, Masoud
Multivalent vaccines against new SARS-CoV-2 hybrid variants
title Multivalent vaccines against new SARS-CoV-2 hybrid variants
title_full Multivalent vaccines against new SARS-CoV-2 hybrid variants
title_fullStr Multivalent vaccines against new SARS-CoV-2 hybrid variants
title_full_unstemmed Multivalent vaccines against new SARS-CoV-2 hybrid variants
title_short Multivalent vaccines against new SARS-CoV-2 hybrid variants
title_sort multivalent vaccines against new sars-cov-2 hybrid variants
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212962/
https://www.ncbi.nlm.nih.gov/pubmed/35757082
http://dx.doi.org/10.1016/j.vacun.2022.06.002
work_keys_str_mv AT ghazvinikiarash multivalentvaccinesagainstnewsarscov2hybridvariants
AT keikhamasoud multivalentvaccinesagainstnewsarscov2hybridvariants